Edit |   |
---|---|
Antigenic Specificity | CD20 (Rituximab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1(N297A)-kappa |
Format | Protein A/G purified, low endotoxin |
Size | 5mg |
Concentration | 1.0 - 5.0 mg/ml |
Applications | RUO |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: N297A detects human CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Rituximab. Rituximab is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab is produced by mammalian cell (Chinese Hamster Ovary). |
Immunogen | n/a |
Other Names | B-lymphocyte surface antigen B1, Bp35, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A member 1, MS4A1 |
Gene, Accession # | UniProt: P11836 |
Catalog # | ICH4011N297A-5mg |
Price | $718 |
Order / More Info | CD20 (Rituximab biosimilar) Antibody from ICHORBIO |
Product Specific References | n/a |
U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio